Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]

Atezolizumab with chemotherapy improves PFS in squamous NSCLC

Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA

Atezolizumab with chemotherapy improves PFS in squamous NSCLC ( Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA )

Editor’s Choice for May 2018

Prof Gordon McVie - Founding Editor, ecancer

Editor’s Choice for May 2018 ( Prof Gordon McVie - Founding Editor, ecancer )

Identifying drivers of resistance in childhood brain tumours

Dr Pratiti Bandopadhayay - Dana-Farber Cancer Institute, Boston, USA

Identifying drivers of resistance in childhood brain tumours ( Dr Pratiti Bandopadhayay - Dana-Farber Cancer Institute, Boston, USA )

Managing infections in patients with multiple myeloma

Dr Joan Bladé - Hospital Clínic Barcelona, Barcelona, Spain

Managing infections in patients with multiple myeloma ( Dr Joan Bladé - Hospital Clínic Barcelona, Barcelona, Spain )

Incorporating patient perspective during myeloma treatment

Dr Karthik Ramasamy - Oxford University Hospital, Oxford, UK

Incorporating patient perspective during myeloma treatment ( Dr Karthik Ramasamy - Oxford University Hospital, Oxford, UK )

Dose escalation of durvalumab with tremelimumab for metastatic urothelial cancer

Dr Arjun Balar - NYU Langone Medical Center, New York, USA

Dose escalation of durvalumab with tremelimumab for metastatic urothelial cancer ( Dr Arjun Balar - NYU Langone Medical Center, New York, USA )

Neoadjuvant nivolumab for resectable lung cancer

Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA

Neoadjuvant nivolumab for resectable lung cancer ( Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA )

Biomarkers of pembrolizumab response in head and neck cancer

Dr Tanguy Seiwert - The University of Chicago Medicine, Chicago, USA

Biomarkers of pembrolizumab response in head and neck cancer ( Dr Tanguy Seiwert - The University of Chicago Medicine, Chicago, USA )

Phase I taselisib results and a cell-free DNA assay

Dr José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA

Phase I taselisib results and a cell-free DNA assay ( Dr José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA )

Front-line therapy of DIPG using IDO inhibitor with radiation and chemotherapy

Dr Theodore Johnson - Georgia Cancer Center, Augusta, USA

Front-line therapy of DIPG using IDO inhibitor with radiation and chemotherapy ( Dr Theodore Johnson - Georgia Cancer Center, Augusta, USA )

AKT inhibitors in research and application

Dr Brian Schwartz - ArQule, Burlington, USA

AKT inhibitors in research and application ( Dr Brian Schwartz - ArQule, Burlington, USA )

Effects of dasatinib on xenograft lung tumour models with YES1 overexpression

Dr Irati Garmendia - University of Navarra, Pamplona, Spain

Effects of dasatinib on xenograft lung tumour models with YES1 overexpression ( Dr Irati Garmendia - University of Navarra, Pamplona, Spain )

More from ecancer